Promise Bio

Promise Bio develops a computational platform using epiproteomics and AI to predict patient responses to treatments for immune-mediated diseases and aid in drug development. Its PROMISE platform analyzes protein modifications to provide a more precise understanding of disease mechanisms, enabling personalized medicine approaches. This technology aims to improve treatment efficacy and reduce the trial-and-error process in autoimmune disease treatment.

+ 0 Upvotes
Buy Funded Startups lists